Foresite Capital Management III as of June 30, 2018
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 24 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 24.9 | $115M | 1.7M | 67.55 | |
| Immunomedics | 13.0 | $60M | 2.5M | 23.67 | |
| Alder Biopharmaceuticals | 10.0 | $47M | 2.9M | 15.80 | |
| Arcus Biosciences Incorporated (RCUS) | 9.1 | $42M | 3.4M | 12.24 | |
| Achaogen | 5.4 | $25M | 2.9M | 8.66 | |
| Aimmune Therapeutics | 4.9 | $23M | 851k | 26.89 | |
| Cymabay Therapeutics | 4.5 | $21M | 1.6M | 13.42 | |
| Myokardia | 4.2 | $20M | 393k | 49.65 | |
| Blueprint Medicines (BPMC) | 3.4 | $16M | 250k | 63.48 | |
| Acceleron Pharma | 2.9 | $14M | 279k | 48.52 | |
| Epizyme | 2.7 | $13M | 941k | 13.55 | |
| Ascendis Pharma A S (ASND) | 2.7 | $13M | 192k | 66.52 | |
| Audentes Therapeutics | 2.6 | $12M | 315k | 38.21 | |
| Solid Biosciences | 2.6 | $12M | 338k | 35.63 | |
| Verona Pharma Plc ads (VRNA) | 1.5 | $6.9M | 503k | 13.66 | |
| Aclaris Therapeutics (ACRS) | 1.3 | $6.2M | 312k | 19.97 | |
| Biohaven Pharmaceutical Holding | 0.9 | $4.2M | 106k | 39.52 | |
| Sangamo Biosciences (SGMO) | 0.8 | $3.8M | 266k | 14.20 | |
| Immunomedics Inc Cmn Stk cmn | 0.8 | $3.6M | 150k | 23.67 | |
| Immunomedics Inc Cmn Stk cmn | 0.8 | $3.6M | 150k | 23.67 | |
| Wave Life Sciences (WVE) | 0.6 | $2.9M | 75k | 38.25 | |
| Tocagen | 0.3 | $1.4M | 149k | 9.34 | |
| Ardelyx (ARDX) | 0.1 | $482k | 130k | 3.70 | |
| BioDelivery Sciences International | 0.0 | $58k | 20k | 2.97 |
